Kytril and Purulence - a phase IV clinical study of FDA data

Summary:

Purulence is reported as a side effect among people who take Kytril (granisetron hydrochloride), especially for people who are female, 50-59 old, have been taking the drug for < 1 month also take Zometa, and have Breast cancer metastatic.

The phase IV clinical study analyzes which people have Purulence when taking Kytril. It is created by eHealthMe based on reports of 10,727 people who have side effects when taking Kytril from the FDA, and is updated regularly.

What is Kytril?

Kytril has active ingredients of granisetron hydrochloride. eHealthMe is studying from 10,766 Kytril users. Check the latest studies of Kytril.

What is Purulence?

Purulence (containing pus) is found to be associated with 454 drugs and 530 conditions by eHealthMe. Check the latest studies of Purulence.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 31, 2026

10,727 people reported to have side effects when taking Kytril.
Among them, 13 people (0.12%) have Purulence.

Among these 13 people:

How long have people been on Kytril when they have Purulence? *

What is the gender of people who have Purulence when taking Kytril? *

female: 92.31 %
male: 7.69 %

What is the age of people who have Purulence when taking Kytril? *

What are other drugs people take besides Kytril? *

What are other side effects people have besides Purulence? *

Bone Disorder: 9 people, 69.23%
Death: 8 people, 61.54%
Jaw Disorder (jaw disease): 7 people, 53.85%
Inflammation: 7 people, 53.85%
Bone Fragmentation: 7 people, 53.85%
Tooth Disorder (tooth disease): 7 people, 53.85%
Aseptic Necrosis (the death of bone tissue due to a lack of blood supply): 7 people, 53.85%
Metastases To Bone (cancer spreads to bone): 6 people, 46.15%
Pain: 6 people, 46.15%
Oral Pain: 6 people, 46.15%

What are the existing conditions these people have? *

Breast Cancer Metastatic: 4 people, 30.77%
Metastases To Bone (cancer spreads to bone): 3 people, 23.08%
Breast Cancer: 3 people, 23.08%
Stomatitis (inflammation of mucous membrane of mouth): 1 person, 7.69%
Oligodendroglioma (a type of glioma that are believed to originate from the oligodendrocytes of the brain or from a glial precursor cell): 1 person, 7.69%
Breast Cancer Recurrent: 1 person, 7.69%
Anaplastic Astrocytoma (tumour of the glial (supportive) tissue of the brain): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Kytril and have Purulence?

- Check whether Purulence is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Kytril:

Kytril (10,766 reports)

Purulence treatments and more:

Purulence (2,822 reports)

Browse all side effects of Kytril:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Purulence:

Purulence (454 drugs)

Browse all the conditions that are associated with Purulence:

Purulence (530 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on granisetron hydrochloride (the active ingredients of Kytril) and Kytril (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.